{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:49:47Z","timestamp":1792144187612,"version":"4.4.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08948-8","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:05:12Z","timestamp":1789614312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PAFAH1B1 stabilization, through PUM2-mediated competitive binding with miRNAs on its\u2019 3\u2019-UTR, takes active actions on ferroptosis to overcome the radioresistance to 125I radioactive particles of pancreatic ductal adenocarcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Yiliang","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4191-6779","authenticated-orcid":false,"given":"Min","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"issue":"10242","key":"8948_CR1","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, et al. Pancreatic cancer. Lancet. 2020;395(10242):2008\u201320.","journal-title":"Lancet"},{"issue":"1","key":"8948_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"8948_CR3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, et al. Pancreatic cancer: Advances and challenges. Cell. 2023;186(8):1729\u201354.","journal-title":"Cell"},{"issue":"1","key":"8948_CR4","doi-asserted-by":"publisher","first-page":"2129884","DOI":"10.1080\/08941939.2022.2129884","volume":"36","author":"HM Kolbeinsson","year":"2023","unstructured":"Kolbeinsson HM, et al. Pancreatic Cancer: A Review of Current Treatment and Novel Therapies. J Invest Surg. 2023;36(1):2129884.","journal-title":"J Invest Surg"},{"issue":"3","key":"8948_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.soc.2023.02.001","volume":"32","author":"S Gottumukkala","year":"2023","unstructured":"Gottumukkala S, Salamekh S, Sanford NN. Current State and Future Directions of Radiation Therapy for Pancreas Adenocarcinoma. Surg Oncol Clin N Am. 2023;32(3):399\u2013414.","journal-title":"Surg Oncol Clin N Am"},{"issue":"5","key":"8948_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"22","key":"8948_CR7","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 2022;289(22):7038\u201350.","journal-title":"FEBS J"},{"key":"8948_CR8","doi-asserted-by":"publisher","first-page":"773909","DOI":"10.3389\/fphar.2021.773909","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Kang R, Tang D. The Art of War: Ferroptosis and Pancreatic Cancer. Front Pharmacol. 2021;12:773909.","journal-title":"Front Pharmacol"},{"issue":"1","key":"8948_CR9","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1038\/s41467-020-20154-8","volume":"11","author":"E Dai","year":"2020","unstructured":"Dai E, et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173\/STING-dependent DNA sensor pathway. Nat Commun. 2020;11(1):6339.","journal-title":"Nat Commun"},{"issue":"1","key":"8948_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/0118744710262369231110065230","volume":"17","author":"FJ Zefrei","year":"2024","unstructured":"Zefrei FJ, et al. Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy. Curr Radiopharm. 2024;17(1):14\u201329.","journal-title":"Curr Radiopharm"},{"issue":"2","key":"8948_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei G, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020;30(2):146\u201362.","journal-title":"Cell Res"},{"issue":"22","key":"8948_CR12","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1101\/gad.1478706","volume":"20","author":"N Bardeesy","year":"2006","unstructured":"Bardeesy N, et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 2006;20(22):3130\u201346.","journal-title":"Genes Dev"},{"key":"8948_CR13","doi-asserted-by":"publisher","first-page":"697308","DOI":"10.3389\/fonc.2021.697308","volume":"11","author":"B Hu","year":"2021","unstructured":"Hu B, et al. Identification of Key Genes Mutations Associated With the Radiosensitivity by Whole Exome Sequencing in Pancreatic Cancer. Front Oncol. 2021;11:697308.","journal-title":"Front Oncol"},{"key":"8948_CR14","doi-asserted-by":"publisher","first-page":"1226044","DOI":"10.3389\/fcell.2023.1226044","volume":"11","author":"HT Endale","year":"2023","unstructured":"Endale HT, Tesfaye W, Mengstie TA. ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol. 2023;11:1226044.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"8948_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbrc.2011.04.117","volume":"409","author":"Z Xing","year":"2011","unstructured":"Xing Z, et al. The human LIS1 is downregulated in hepatocellular carcinoma and plays a tumor suppressor function. Biochem Biophys Res Commun. 2011;409(2):193\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"8948_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.lungcan.2012.05.105","volume":"77","author":"FY Lo","year":"2012","unstructured":"Lo FY, et al. Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer. Lung Cancer. 2012;77(3):585\u201392.","journal-title":"Lung Cancer"},{"issue":"3","key":"8948_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.2889","volume":"46","author":"B Zimdahl","year":"2014","unstructured":"Zimdahl B, et al. Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia. Nat Genet. 2014;46(3):245\u201352.","journal-title":"Nat Genet"},{"issue":"7","key":"8948_CR18","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.7150\/jca.17635","volume":"8","author":"FM Brehar","year":"2017","unstructured":"Brehar FM, et al. Preferential Association of Lissencephaly-1 Gene Expression with CD133\u2009+\u2009Glioblastoma Cells. J Cancer. 2017;8(7):1284\u201391.","journal-title":"J Cancer"},{"key":"8948_CR19","doi-asserted-by":"crossref","unstructured":"Li L, et al. LIS1 interacts with CLIP170 to promote tumor growth and metastasis via the Cdc42 signaling pathway in salivary gland adenoid cystic carcinoma. Int J Oncol. 2022;61(4).","DOI":"10.3892\/ijo.2022.5419"},{"issue":"1","key":"8948_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12935-024-03241-4","volume":"24","author":"Z Wei","year":"2024","unstructured":"Wei Z, et al. MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1. Cancer Cell Int. 2024;24(1):129.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"8948_CR21","doi-asserted-by":"publisher","first-page":"110235","DOI":"10.1016\/j.jbc.2025.110235","volume":"301","author":"PR Majmudar","year":"2025","unstructured":"Majmudar PR, Keri RA. The neural stem cell gene PAFAH1B1 controls cell cycle progression, DNA integrity, and paclitaxel sensitivity of triple-negative breast cancer cells. J Biol Chem. 2025;301(6):110235.","journal-title":"J Biol Chem"},{"key":"8948_CR22","doi-asserted-by":"crossref","unstructured":"Glass M, Michl P, Huttelmaier AS. RNA binding proteins as drivers and therapeutic target candidates in pancreatic ductal adenocarcinoma. Int J Mol Sci. 2020;21(11).","DOI":"10.3390\/ijms21114190"},{"issue":"4","key":"8948_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.molcel.2018.11.034","volume":"73","author":"D D\u2019Amico","year":"2019","unstructured":"D\u2019Amico D, et al. The RNA-Binding Protein PUM2 Impairs Mitochondrial Dynamics and Mitophagy During Aging. Mol Cell. 2019;73(4):775\u2013e78710.","journal-title":"Mol Cell"},{"issue":"9","key":"8948_CR24","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.7150\/ijbs.83348","volume":"19","author":"J Li","year":"2023","unstructured":"Li J, et al. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int J Biol Sci. 2023;19(9):2756\u201371.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"8948_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 2023;14(8):519.","journal-title":"Cell Death Dis"},{"key":"8948_CR26","doi-asserted-by":"crossref","unstructured":"Smialek MJ, et al. Role of PUM RNA-binding proteins in cancer. Cancers (Basel). 2021;13(1).","DOI":"10.3390\/cancers13010129"},{"issue":"4","key":"8948_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1101\/gad.182568.111","volume":"26","author":"WO Miles","year":"2012","unstructured":"Miles WO, et al. Pumilio facilitates miRNA regulation of the E2F3 oncogene. Genes Dev. 2012;26(4):356\u201368.","journal-title":"Genes Dev"},{"issue":"1","key":"8948_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12964-025-02103-4","volume":"23","author":"X Ren","year":"2025","unstructured":"Ren X, et al. REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR signaling. Cell Commun Signal. 2025;23(1):96.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"8948_CR29","first-page":"360","volume":"11","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, et al. (125)I Radioactive Particles Drive Protective Autophagy in Hepatocellular Carcinoma by Upregulating ATG9B. J Clin Transl Hepatol. 2023;11(2):360\u20138.","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"8948_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41374-021-00690-7","volume":"102","author":"D Mohapatra","year":"2022","unstructured":"Mohapatra D, et al. Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and\/or TGF-beta-induced tumor-associated fibrosis. Lab Invest. 2022;102(3):298\u2013311.","journal-title":"Lab Invest"},{"issue":"1","key":"8948_CR31","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s12672-024-01627-4","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang M, et al. Comprehensive characterization of neddylation related genes in cutaneous melanoma identified a novel prognostic signature for treatment outcomes, immune landscape. Discov Oncol. 2024;15(1):722.","journal-title":"Discov Oncol"},{"issue":"6","key":"8948_CR32","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1177\/1533034617732204","volume":"16","author":"J Zhang","year":"2017","unstructured":"Zhang J, et al. The Combined Antitumor Effects of (125)I Radioactive Particle Implantation and Cytokine-Induced Killer Cell Therapy on Xenograft Hepatocellular Carcinoma in a Mouse Model. Technol Cancer Res Treat. 2017;16(6):1083\u201391.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"8948_CR33","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s12672-025-03074-1","volume":"16","author":"H Ma","year":"2025","unstructured":"Ma H, et al. Comprehensive characterization of NK cell-related genes in cutaneous melanoma identified a novel prognostic signature for predicting the prognosis, immunotherapy, and chemotherapy efficacy. Discov Oncol. 2025;16(1):1243.","journal-title":"Discov Oncol"},{"issue":"11","key":"8948_CR34","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","volume":"12","author":"G Lei","year":"2021","unstructured":"Lei G, et al. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell. 2021;12(11):836\u201357.","journal-title":"Protein Cell"},{"key":"8948_CR35","doi-asserted-by":"publisher","first-page":"1085581","DOI":"10.3389\/fonc.2023.1085581","volume":"13","author":"Z Lu","year":"2023","unstructured":"Lu Z, et al. The potential of ferroptosis combined with radiotherapy in cancer treatment. Front Oncol. 2023;13:1085581.","journal-title":"Front Oncol"},{"issue":"2","key":"8948_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.numecd.2021.10.017","volume":"32","author":"JK Zhang","year":"2022","unstructured":"Zhang JK, et al. The BMSC-derived exosomal lncRNA Mir9-3hg suppresses cardiomyocyte ferroptosis in ischemia-reperfusion mice via the Pum2\/PRDX6 axis. Nutr Metab Cardiovasc Dis. 2022;32(2):515\u201327.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"8948_CR37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11010-022-04534-w","volume":"478","author":"Q Liu","year":"2023","unstructured":"Liu Q, et al. PUM2 aggravates the neuroinflammation and brain damage induced by ischemia-reperfusion through the SLC7A11-dependent inhibition of ferroptosis via suppressing the SIRT1. Mol Cell Biochem. 2023;478(3):609\u201320.","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"8948_CR38","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1002\/tox.24310","volume":"39","author":"Y Meng","year":"2024","unstructured":"Meng Y, et al. PUM2 promoted osteoarthritis progression through PTEN-mediated chondrocyte ferroptosis by facilitating NEDD4 mRNA degradation. Environ Toxicol. 2024;39(9):4318\u201332.","journal-title":"Environ Toxicol"},{"key":"8948_CR39","doi-asserted-by":"crossref","unstructured":"Benkhaled S, et al. Combination, modulation and interplay of modern radiotherapy with the tumor microenvironment and targeted therapies in pancreatic cancer: Which candidates to boost radiotherapy? Cancers (Basel). 2023;15(3).","DOI":"10.3390\/cancers15030768"},{"issue":"5247","key":"8948_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1126\/science.271.5247.350","volume":"271","author":"SA Hahn","year":"1996","unstructured":"Hahn SA, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996;271(5247):350\u20133.","journal-title":"Science"},{"key":"8948_CR41","doi-asserted-by":"crossref","unstructured":"AlMasri SS, Hammad MZA, Singhi AD, 1, Paniccia A, Lee KK, Aldakkak M, Evans DB, Tsai S, Zureikat AH, Ellsworth S. Implications of SMAD4 Status in pancreatic carcinoma treated with radiation therapy: a multi-institutional analysis. Int J Radiat Oncol Biol Phys. 2021;111(3):S145.","DOI":"10.1016\/j.ijrobp.2021.07.326"},{"issue":"4","key":"8948_CR42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/1221","volume":"19","author":"S Hirotsune","year":"1998","unstructured":"Hirotsune S, et al. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet. 1998;19(4):333\u20139.","journal-title":"Nat Genet"},{"issue":"5","key":"8948_CR43","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1523\/JNEUROSCI.23-05-01719.2003","volume":"23","author":"MJ Gambello","year":"2003","unstructured":"Gambello MJ, et al. Multiple dose-dependent effects of Lis1 on cerebral cortical development. J Neurosci. 2003;23(5):1719\u201329.","journal-title":"J Neurosci"},{"issue":"4","key":"8948_CR44","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbrc.2011.02.086","volume":"406","author":"J Hao","year":"2011","unstructured":"Hao J, et al. MicroRNA 421 suppresses DPC4\/Smad4 in pancreatic cancer. Biochem Biophys Res Commun. 2011;406(4):552\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"25","key":"8948_CR45","doi-asserted-by":"publisher","first-page":"21046","DOI":"10.18632\/oncotarget.4124","volume":"6","author":"X Xia","year":"2015","unstructured":"Xia X, et al. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4. Oncotarget. 2015;6(25):21046\u201363.","journal-title":"Oncotarget"},{"issue":"12","key":"8948_CR46","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrclinonc.2012.194","volume":"9","author":"DA Jaffray","year":"2012","unstructured":"Jaffray DA. Image-guided radiotherapy: from current concept to future perspectives. Nat Rev Clin Oncol. 2012;9(12):688\u201399.","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"8948_CR47","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, et al. Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11. Cancer Discov. 2019;9(12):1673\u201385.","journal-title":"Cancer Discov"},{"key":"8948_CR48","doi-asserted-by":"crossref","unstructured":"Wang M, et al. The PUF protein family: overview on PUF RNA targets, biological functions, and post transcriptional regulation. Int J Mol Sci. 2018;19(2).","DOI":"10.3390\/ijms19020410"},{"issue":"1","key":"8948_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1247\/csf.18030","volume":"44","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. PUM2 Promotes Glioblastoma Cell Proliferation and Migration via Repressing BTG1 Expression. Cell Struct Funct. 2019;44(1):29\u201339.","journal-title":"Cell Struct Funct"},{"issue":"1","key":"8948_CR50","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/s41467-022-29309-1","volume":"13","author":"Y Gong","year":"2022","unstructured":"Gong Y, et al. PUMILIO proteins promote colorectal cancer growth via suppressing p21. Nat Commun. 2022;13(1):1627.","journal-title":"Nat Commun"},{"issue":"1","key":"8948_CR51","doi-asserted-by":"publisher","first-page":"15316","DOI":"10.1038\/s41598-018-33596-4","volume":"8","author":"EL Sternburg","year":"2018","unstructured":"Sternburg EL, et al. Antagonistic and cooperative AGO2-PUM interactions in regulating mRNAs. Sci Rep. 2018;8(1):15316.","journal-title":"Sci Rep"},{"issue":"6","key":"8948_CR52","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jgg.2023.01.008","volume":"50","author":"B Gong","year":"2023","unstructured":"Gong B, et al. Epigenetic and transcriptional activation of the secretory kinase FAM20C as an oncogene in glioma. J Genet Genomics. 2023;50(6):422\u201333.","journal-title":"J Genet Genomics"},{"issue":"906","key":"8948_CR53","doi-asserted-by":"publisher","first-page":"eadu7145","DOI":"10.1126\/scisignal.adu7145","volume":"18","author":"PS Hibshman","year":"2025","unstructured":"Hibshman PS, et al. Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer. Sci Signal. 2025;18(906):eadu7145.","journal-title":"Sci Signal"},{"issue":"2","key":"8948_CR54","doi-asserted-by":"publisher","first-page":"101179","DOI":"10.1016\/j.gendis.2023.101179","volume":"12","author":"R Zhang","year":"2025","unstructured":"Zhang R, et al. FAM20C: A key protein kinase in multiple diseases. Genes Dis. 2025;12(2):101179.","journal-title":"Genes Dis"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08948-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:34:08Z","timestamp":1792143248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08948-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8948"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08948-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study involving clinical specimens was approved by the Ethics Committee of the First Medical Center of PLA General Hospital and performed in accordance with the Declaration of Helsinki. Written consents were obtained from all participants. This animal study was approved by the Ethics Committee of the First Medical Center of PLA General Hospital. All the animal procedures were performed in accordance with the ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1311"}}